S7

Overview

S7 is an inhibitory polypeptide targeting IL-6R , which specifically binds to IL-6R and its A chain ( gp80/IL-6RA ) to block its signal transduction. S7 inhibits IL-6-mediated anti-apoptosis ( apoptosis ), angiogenesis and the expression of VEGF-A , blocks related survival signaling pathways, and enhances the sensitivity of cancer cells to chemotherapeutic drugs. S7 can be applied to the research of related diseases such as cervical cancer , multiple myeloma, Kaposi's sarcoma, prostate cancer and basal cell carcinoma.

Application

Products | Products > Peptides | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Heart Disease | Products > Disease Areas > Heart Failure | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Cancer | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cardiovascular Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Interleukin Related | Products > Signaling Pathways > VEGFR | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-P10284
• CAS No.: 853248-13-2
• Molecular Formula: C37H70N10O10
• Molecular Weight: 815.01
• Purity: 98.10%
• Storage: Sealed storage, away from moisture. Powder -80°C, 2 years , -20°C, 1 year * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Availability: In-stock

Source

Original product source